Spanish Red Biotech Pipeline

MSD

ZINPLAVA

Type: Biodrugs/ Drugs
Therapeutic area: Infections
Indication: in Children Aged 1 to <18 Years Receiving Antibacterial Drug Treatment for C. difficile Infection (Toxin B)
Phase: 3Phase III in Spain, 2Phase II, 1Phase I